163 related articles for article (PubMed ID: 8104576)
1. Increased levels of serum intercellular adhesion molecule 1 in HIV infection are related to immune activation.
Diez-Ruiz A; Kaiser G; Jäger H; Birkmann J; Tilz GP; Wachter H; Fuchs D
Int Arch Allergy Immunol; 1993; 102(1):56-60. PubMed ID: 8104576
[TBL] [Abstract][Full Text] [Related]
2. Increased concentrations of soluble tumor necrosis factor receptor 75 but not of soluble intercellular adhesion molecule-1 are associated with the decline of CD4+ lymphocytes in HIV infection.
Zangerle R; Fuchs D; Sarcletti M; Gallati H; Reibnegger G; Wachter H; Dierich MP; Möst J
Clin Immunol Immunopathol; 1994 Sep; 72(3):328-34. PubMed ID: 7914841
[TBL] [Abstract][Full Text] [Related]
3. Abnormal levels of circulating adhesion molecules in HIV-1 infection with characteristic alterations in opportunistic infections.
Nordøy I; Aukrust P; Müller F; Frøland SS
Clin Immunol Immunopathol; 1996 Oct; 81(1):16-21. PubMed ID: 8808636
[TBL] [Abstract][Full Text] [Related]
4. Elevated concentrations of circulating intercellular adhesion molecule 1 (ICAM-1) in HIV-1 infection.
Möst J; Zangerle R; Herold M; Fuchs D; Wachter H; Fritsch P; Dierich MP
J Acquir Immune Defic Syndr (1988); 1993 Mar; 6(3):221-6. PubMed ID: 8095541
[TBL] [Abstract][Full Text] [Related]
5. Clinical and laboratory predictors of survival in Gambian patients with symptomatic HIV-1 or HIV-2 infection.
Whittle H; Egboga A; Todd J; Corrah T; Wilkins A; Demba E; Morgan G; Rolfe M; Berry N; Tedder R
AIDS; 1992 Jul; 6(7):685-9. PubMed ID: 1354448
[TBL] [Abstract][Full Text] [Related]
6. Immune serum markers and CD4 cell counts in HIV-infected intravenous drug users.
Chaisson RE; Taylor E; Margolick JB; Muñoz A; Solomon L; Cohn S; Nelson KE; Vlahov D
J Acquir Immune Defic Syndr (1988); 1992; 5(5):456-60. PubMed ID: 1348535
[TBL] [Abstract][Full Text] [Related]
7. The effect of zidovudine treatment on serum neopterin and beta 2-microglobulin levels in mildly symptomatic, HIV type 1 seropositive individuals.
Bass HZ; Hardy WD; Mitsuyasu RT; Taylor JM; Wang YX; Fischl MA; Spector SA; Richman DD; Fahey JL
J Acquir Immune Defic Syndr (1988); 1992; 5(3):215-21. PubMed ID: 1346807
[TBL] [Abstract][Full Text] [Related]
8. The prognostic value of cellular and serologic markers in infection with human immunodeficiency virus type 1.
Fahey JL; Taylor JM; Detels R; Hofmann B; Melmed R; Nishanian P; Giorgi JV
N Engl J Med; 1990 Jan; 322(3):166-72. PubMed ID: 1967191
[TBL] [Abstract][Full Text] [Related]
9. Immune activation markers and AIDS prognosis.
Osmond DH; Shiboski S; Bacchetti P; Winger EE; Moss AR
AIDS; 1991 May; 5(5):505-11. PubMed ID: 1677808
[TBL] [Abstract][Full Text] [Related]
10. Serum and cerebrospinal fluid levels of soluble intercellular adhesion molecule 1 (sICAM-1) in patients with HIV-1 associated neurological diseases.
Heidenreich F; Arendt G; Jander S; Jablonowski H; Stoll G
J Neuroimmunol; 1994 Jul; 52(2):117-26. PubMed ID: 7913474
[TBL] [Abstract][Full Text] [Related]
11. Increased serum neopterin in patients with HIV-1 infection is correlated with reduced in vitro interleukin-2 production.
Fuchs D; Shearer GM; Boswell RN; Clerici M; Reibnegger G; Werner ER; Zajac RA; Wachter H
Clin Exp Immunol; 1990 Apr; 80(1):44-8. PubMed ID: 1969780
[TBL] [Abstract][Full Text] [Related]
12. Serum intercellular adhesion molecule-1 in alcoholic liver disease and its relationship with histological disease severity.
Douds AC; Lim AG; Jazrawi RP; Finlayson C; Maxwell JD
J Hepatol; 1997 Feb; 26(2):280-6. PubMed ID: 9059947
[TBL] [Abstract][Full Text] [Related]
13. Immune changes in HIV-1 infection: significant correlations and differences in serum markers and lymphoid phenotypic antigens.
Bass HZ; Nishanian P; Hardy WD; Mitsuyasu RT; Esmail E; Cumberland W; Fahey JL
Clin Immunol Immunopathol; 1992 Jul; 64(1):63-70. PubMed ID: 1376654
[TBL] [Abstract][Full Text] [Related]
14. Correlation between surrogate markers, viral load, and disease progression in HIV-1 infection.
Lafeuillade A; Tamalet C; Pellegrino P; de Micco P; Vignoli C; Quilichini R
J Acquir Immune Defic Syndr (1988); 1994 Oct; 7(10):1028-33. PubMed ID: 7916049
[TBL] [Abstract][Full Text] [Related]
15. Neopterin and beta 2-microglobulin as prognostic indices in human immunodeficiency virus type 1 infection.
Fuchs D; Krämer A; Reibnegger G; Werner ER; Dierich MP; Goedert JJ; Wachter H
Infection; 1991; 19 Suppl 2():S98-102. PubMed ID: 1673120
[TBL] [Abstract][Full Text] [Related]
16. Serum nitrite plus nitrate in infection with human immunodeficiency virus type-1.
Zangerle R; Fuchs D; Reibnegger G; Werner-Felmayer G; Gallati H; Wachter H; Werner ER
Immunobiology; 1995 Jun; 193(1):59-70. PubMed ID: 7590863
[TBL] [Abstract][Full Text] [Related]
17. Negative correlation between blood cell counts and serum neopterin concentration in patients with HIV-1 infection.
Fuchs D; Shearer GM; Boswell RN; Lucey DR; Clerici M; Reibnegger G; Werner ER; Zajac RA; Wachter H
AIDS; 1991 Feb; 5(2):209-12. PubMed ID: 1674419
[TBL] [Abstract][Full Text] [Related]
18. Elevated concentrations of circulating intercellular adhesion molecule 1 (ICAM-1) and of vascular cell adhesion molecule 1 (VCAM-1) in HIV-1 infection.
Gattegno L; Bentata-Peyssare M; Gronowski S; Chaouche K; Ferriere F
Cell Adhes Commun; 1995 Aug; 3(3):179-85. PubMed ID: 8846020
[TBL] [Abstract][Full Text] [Related]
19. Early markers of HIV infection and subclinical disease progression.
Dolan MJ; Lucey DR; Hendrix CW; Melcher GP; Spencer GA; Boswell RN
Vaccine; 1993; 11(5):548-51. PubMed ID: 8098175
[TBL] [Abstract][Full Text] [Related]
20. Serum levels of intercellular adhesion molecule 1 in patients with HIV-related Kaposi's sarcoma.
De Paoli P; Caffau C; D'Andrea M; Tavio M; Tirelli U; Santini G
J Acquir Immune Defic Syndr (1988); 1994 Jul; 7(7):695-9. PubMed ID: 7911526
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]